These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29681575)
1. Sinus Standstill in a Patient after Intracoronary Papaverine Administration for a Coronary Fractional Flow Reserve. Nauchi M; Sakai T; Yamawaki M; Ito Y Int Heart J; 2018 May; 59(3):630-633. PubMed ID: 29681575 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter. Okabe Y; Otowa K; Mitamura Y; Murai H; Usui S; Kaneko S; Takamura M Heart Vessels; 2018 Nov; 33(11):1358-1364. PubMed ID: 29713819 [TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement. Inoue K; Sonoda S; Naka Y; Okabe H; Setoyama K; Miura T; Anai R; Araki M; Kataoka M Int Heart J; 2021 Sep; 62(5):962-969. PubMed ID: 34544970 [TBL] [Abstract][Full Text] [Related]
4. Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine. Nakayama M; Tanaka N; Yamashita J; Iwasaki K Cardiovasc Interv Ther; 2020 Oct; 35(4):371-378. PubMed ID: 31939068 [TBL] [Abstract][Full Text] [Related]
5. Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease. Nakayama M; Tanaka N; Sakoda K; Hokama Y; Hoshino K; Kimura Y; Ogawa M; Yamashita J; Kobori Y; Uchiyama T; Aizawa Y; Yamashina A Circ J; 2015; 79(3):530-6. PubMed ID: 25746536 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve. Nishi T; Kitahara H; Iwata Y; Fujimoto Y; Nakayama T; Takahara M; Sugimoto K; Kobayashi Y J Cardiol; 2016 Dec; 68(6):512-516. PubMed ID: 26811149 [TBL] [Abstract][Full Text] [Related]
7. Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation. Goto M; Sato M; Kitazawa H; Takahashi M; Fuse K; Saito A; Okabe M; Aizawa Y Intern Med; 2014; 53(15):1629-31. PubMed ID: 25088875 [TBL] [Abstract][Full Text] [Related]
8. Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases. Nakayama M; Saito A; Kitazawa H; Takahashi M; Sato M; Fuse K; Okabe M; Hoshino K; Tanaka N; Yamashina A; Aizawa Y Intern Med; 2012; 51(4):351-6. PubMed ID: 22333368 [TBL] [Abstract][Full Text] [Related]
9. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries. Takeuchi M; Nohtomi Y; Kuroiwa A Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310 [TBL] [Abstract][Full Text] [Related]
10. ST elevation after intracoronary administration of Papaverine for fractional flow reserve estimation. Jain RK; Chitnis NS; Hygriv Rao B Indian Heart J; 2014; 66(3):289-93. PubMed ID: 24973833 [TBL] [Abstract][Full Text] [Related]
11. Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve. Schlundt C; Bietau C; Klinghammer L; Wiedemann R; Rittger H; Ludwig J; Achenbach S Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25908694 [TBL] [Abstract][Full Text] [Related]
12. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522 [TBL] [Abstract][Full Text] [Related]
13. Duration of Hyperemia With Intracoronary Administration of Papaverine. Mizukami T; Sonck J; Gallinoro E; Kodeboina M; Canvedra A; Nagumo S; Bartunek J; Wyffels E; Vanderheyden M; Shinke T; De Bruyne B; Collet C J Am Heart Assoc; 2021 Feb; 10(3):e018562. PubMed ID: 33459027 [No Abstract] [Full Text] [Related]
14. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans? Rossen JD; Nahser PJ; Oskarsson H; Brown RE; Winniford MD Coron Artery Dis; 1996 Jun; 7(6):479-84. PubMed ID: 8889365 [TBL] [Abstract][Full Text] [Related]
15. Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR). Röther J; Achenbach S; Tröbs M; Blachutzik F; Nef H; Marwan M; Schlundt C Clin Res Cardiol; 2016 Dec; 105(12):1003-1010. PubMed ID: 27307094 [TBL] [Abstract][Full Text] [Related]
16. Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases. Zhang X; Shen W; Cai X; Zheng A Chin Med Sci J; 1993 Dec; 8(4):248-9. PubMed ID: 8032075 [TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309 [TBL] [Abstract][Full Text] [Related]
19. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs]. Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511 [TBL] [Abstract][Full Text] [Related]
20. Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial. Ramdjan TT; van der Does LJ; Knops P; Res JC; de Groot NM Trials; 2014 Nov; 15():445. PubMed ID: 25403703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]